Analysts think ACHV stock price could increase by 177%
Oct 24, 2024, 11:26 AM
-10.44%
What does ACHV do
Achieve Life Sciences, based in Seattle, is developing cytisinicline, a plant-based alkaloid, for smoking cessation and nicotine addiction, targeting cravings and withdrawal symptoms. The company employs 22 full-time staff.
10 analysts think ACHV stock price will increase by 176.83%. The current median analyst target is $13.26 compared to a current stock price of $4.79. The lowest analysts target is $10.10 and the highest analyst target is $31.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.